Aquestive Therapeutics
AQST
#6958
Rank
ยฃ0.32 B
Marketcap
ยฃ3.60
Share price
-5.38%
Change (1 day)
178.02%
Change (1 year)

Revenue for Aquestive Therapeutics (AQST)

Revenue in 2024 (TTM): ยฃ46.45 Million

According to Aquestive Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ46.03 Million. In 2023 the company made a revenue of ยฃ39.7 Million an increase over the revenue in the year 2022 that were of ยฃ39.41 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aquestive Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ46.45 M17.01%
2023 ยฃ39.7 M0.74%
2022 ยฃ39.41 M4.66%
2021 ยฃ37.65 M11.95%
2020 ยฃ33.63 M-16.16%
2019 ยฃ40.11 M-24.48%
2018 ยฃ53.12 M7.28%
2017 ยฃ49.51 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.17 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.56 B 1,127.50%๐Ÿ‡บ๐Ÿ‡ธ USA